Cellectar Biosciences Inc (CLRB): Why Are Analysts Bullish About Penny Sto...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	12
Posts	3803
Boards Moderated	0
Alias Born	04/30/2004

abracky

Re: None

Tuesday, 07/06/2021 6:41:34 AM

Tuesday, July 06, 2021 6:41:34 AM

Why Are Analysts Bullish About Penny Stock Cellectar Biosciences?

Source: TipRanks
Cellectar Biosciences (NASDAQ: CLRB) is a late-stage clinical biopharmaceutical company, focused on the development and discovery of drugs that can be used for the treatment of cancer. The company intends to use its proprietary Phospholipid Drug Conjugate (PDC) platform to develop PDCs that can specifically target cancer cells. The company’s drug pipeline includes CLR 131, one preclinical PDC chemotherapeutic program called CLR 1900, and several partnered PDC assets. Q1 Results Cellectar Biosciences had cash and cash equivalents of $53.6 million on its balance sheet as of March 31. While the company did not earn any revenues in Q1, the net loss was $0.13 per share versus a loss of $0.
https://www.tipranks.com/news/article/why-are-analysts-bullish-about-penny-stock-cellectar-biosciences